US study shows that tofacitinib is an efficacious treatment for active RA
Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20...
View ArticleCommon rheumatoid arthritis and psoriasis medications are associated with...
Individuals with systemic inflammatory conditions, such as rheumatoid arthritis (RA) and psoriasis, experience a 1.5 to 2-fold increased rate of cardiovascular disease. Previous research suggests that...
View ArticleNew combo of chemo and well-known malaria drug delivers double punch to tumors
Blocking autophagy -- the process of "self-eating" within cells -- is turning out to be a viable way to enhance the effectiveness of a wide variety of cancer treatments.
View ArticleBlock its recycling system, and cancer kicks the can: study
All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage...
View ArticleUranium exposure linked to high lupus rates in community living near a former...
High rates of systemic lupus erythematosus have been linked to living in proximity to a former uranium ore processing facility in Ohio, according to new research findings presented this week at the...
View ArticleCheaper drugs produce same benefits for rheumatoid arthritis, study finds
James O'Dell, M.D., chief of the Veterans Administration Nebraska-Western Iowa Health Care System's Omaha medical center and the UNMC divisions of rheumatology and immunology, is the primary author of...
View ArticleThe effect on work loss of different treatments for rheumatoid arthritis
Treatment with a biological agent was not superior to conventional treatment in terms of the effect on work loss over 21 months in patients with early rheumatoid arthritis (RA) who responded...
View ArticleExpensive or not, rheumatoid arthritis drugs have similar effect: study
(HealthDay)—Treatment with a pricey biological drug was no better than cheaper, conventional therapy in terms of reducing time off from work for people with rheumatoid arthritis, a new study finds.
View ArticleLong-term antibiotic treatment for Q fever causes weight gain
Scientists have unearthed still more evidence that antibiotics can contribute to obesity. Research published ahead of print in the journal Antimicrobial Agents and Chemotherapy suggests that patients...
View ArticleCommon treatment of certain autoimmune disease does not appear effective
Among patients with the systemic autoimmune disease primary Sjögren syndrome, use of hydroxychloroquine, the most frequently prescribed treatment for the disorder, did not improve symptoms during 24...
View ArticleARVO: Hydroxychloroquine daily dosing recs often exceeded
(HealthDay)—Many patients prescribed hydroxychloroquine exceed the safety guidelines for daily dosing, according to a study presented at the annual meeting of the Association for Research in Vision and...
View ArticlePatients with primary hand OA should not be prescribed hydroxychloroquine
The results of an interventional trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that use of the disease-modifying anti-rheumatic drug...
View Article
More Pages to Explore .....